company background image
OSUR

OraSure Technologies NasdaqGS:OSUR Stock Report

Last Price

US$2.79

Market Cap

US$209.4m

7D

0.4%

1Y

-73.1%

Updated

28 Jun, 2022

Data

Company Financials +
OSUR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

OSUR Stock Overview

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally.

Risk Analysis

No risks detected for OSUR from our risk checks.

OraSure Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OraSure Technologies
Historical stock prices
Current Share PriceUS$2.79
52 Week HighUS$13.57
52 Week LowUS$2.62
Beta-0.23
1 Month Change-35.86%
3 Month Change-60.26%
1 Year Change-73.07%
3 Year Change-69.44%
5 Year Change-84.00%
Change since IPO-49.27%

Recent News & Updates

Jun 14
Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

How far off is OraSure Technologies, Inc. ( NASDAQ:OSUR ) from its intrinsic value? Using the most recent financial...

Jun 10

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

OraSure has pushed lower on the charts in recent times amid a series of headwinds. Qualitatively there are potential upside catalysts yet to be realized by the stock, however, these look to be well priced in already. Fundamentals have softened in recent years and offer a small portion of unrealized value in earnings and FCF for shareholders. We've priced the stock at $2.54 on a composite of several weighting factors, noting several targets below this mark as well. Here are the moving parts of the OSUR investment debate.

Shareholder Returns

OSURUS Medical EquipmentUS Market
7D0.4%3.5%1.7%
1Y-73.1%-25.7%-20.4%

Return vs Industry: OSUR underperformed the US Medical Equipment industry which returned -24% over the past year.

Return vs Market: OSUR underperformed the US Market which returned -18.8% over the past year.

Price Volatility

Is OSUR's price volatile compared to industry and market?
OSUR volatility
OSUR Average Weekly Movement9.4%
Medical Equipment Industry Average Movement10.4%
Market Average Movement8.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.2%

Stable Share Price: OSUR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: OSUR's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000785Carrie Eglinton Mannerhttps://www.orasure.com

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company’s principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test.

OraSure Technologies Fundamentals Summary

How do OraSure Technologies's earnings and revenue compare to its market cap?
OSUR fundamental statistics
Market CapUS$209.40m
Earnings (TTM)-US$46.74m
Revenue (TTM)US$242.80m

0.8x

P/S Ratio

-4.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OSUR income statement (TTM)
RevenueUS$242.80m
Cost of RevenueUS$139.25m
Gross ProfitUS$103.55m
Other ExpensesUS$150.29m
Earnings-US$46.74m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.65
Gross Margin42.65%
Net Profit Margin-19.25%
Debt/Equity Ratio0%

How did OSUR perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is OSUR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OSUR?

Other financial metrics that can be useful for relative valuation.

OSUR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.5x
Enterprise Value/EBITDA-4.6x
PEG Ration/a

Price to Sales Ratio vs Peers

How does OSUR's PS Ratio compare to its peers?

OSUR PS Ratio vs Peers
The above table shows the PS ratio for OSUR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average6.9x
SMTI Sanara MedTech
6.1x36.5%US$163.6m
UTMD Utah Medical Products
6.3xn/aUS$324.3m
MHUA Meihua International Medical Technologies
1.3xn/aUS$126.9m
RXST RxSight
13.8x34.1%US$388.4m
OSUR OraSure Technologies
0.8x-12.5%US$209.4m

Price-To-Sales vs Peers: OSUR is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (6.9x).


Price to Earnings Ratio vs Industry

How does OSUR's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Sales vs Industry: OSUR is good value based on its Price-To-Sales Ratio (0.8x) compared to the US Medical Equipment industry average (4x)


Price to Sales Ratio vs Fair Ratio

What is OSUR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OSUR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: OSUR is expensive based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).


Share Price vs Fair Value

What is the Fair Price of OSUR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OSUR ($2.79) is trading above our estimate of fair value ($2.02)

Significantly Below Fair Value: OSUR is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OSUR's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is OraSure Technologies forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


68.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OSUR is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OSUR is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OSUR is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OSUR's revenue is expected to decline over the next 3 years (-12.5% per year).

High Growth Revenue: OSUR's revenue is forecast to decline over the next 3 years (-12.5% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: OSUR is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has OraSure Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-60.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: OSUR is currently unprofitable.

Growing Profit Margin: OSUR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: OSUR is unprofitable, and losses have increased over the past 5 years at a rate of 60.4% per year.

Accelerating Growth: Unable to compare OSUR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSUR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: OSUR has a negative Return on Equity (-12.81%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is OraSure Technologies's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: OSUR's short term assets ($268.4M) exceed its short term liabilities ($55.6M).

Long Term Liabilities: OSUR's short term assets ($268.4M) exceed its long term liabilities ($15.1M).


Debt to Equity History and Analysis

Debt Level: OSUR is debt free.

Reducing Debt: OSUR has not had any debt for past 5 years.

Debt Coverage: OSUR has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: OSUR has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is OraSure Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate OSUR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OSUR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OSUR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OSUR's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as OSUR has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Carrie Eglinton Manner (46 yo)

no data

Tenure

Ms. Carrie Eglinton Manner serves as President, Chief Executive Officer & Director of OraSure Technologies, Inc. since June 04, 2022. She joined OraSure Technologies, Inc. on June 04, 2022. She serves as a...


Leadership Team

Experienced Management: OSUR's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: OSUR's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

OraSure Technologies, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: OraSure Technologies, Inc.
  • Ticker: OSUR
  • Exchange: NasdaqGS
  • Founded: 2000
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: US$209.396m
  • Shares outstanding: 72.46m
  • Website: https://www.orasure.com

Number of Employees


Location

  • OraSure Technologies, Inc.
  • 220 East First Street
  • Bethlehem
  • Pennsylvania
  • 18015
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/28 00:00
End of Day Share Price2022/06/28 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.